SILO (SILO Pharma) E10: $-20.20 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SILO SILO Pharma Inc SILO
42 GF Score
Price $2.10
GF Value $3.44
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is SILO Pharma E10?

SILO Pharma SILO 42 E10 is $-20.20 as of Jun. 2026. GuruFocus rates SILO with a GF Score™ of 42/100 and a GF Value™ of $3.44 (Possible Value Trap). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

SILO Pharma's adjusted earnings per share data for the three months ended in Jun. 2026 was $-0.760. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-20.20 for the trailing ten years ended in Jun. 2026.

During the past 3 years, the average E10 Growth Rate was -7.80% per year. During the past 5 years, the average E10 Growth Rate was -10.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of SILO Pharma was -7.80% per year. The lowest was -16.20% per year. And the median was -11.10% per year.

As of today (2026-09-11), SILO Pharma's current stock price is $2.10. SILO Pharma's E10 for the quarter that ended in Jun. 2026 was $-20.20. SILO Pharma's Shiller PE Ratio of today is .


SILO Pharma  (NAS:SILO) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


SILO Pharma E10 Related Terms


SILO Pharma E10 Historical Data

* Premium members only.

The historical data trend for SILO Pharma's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SILO Pharma E10 Chart

SILO Pharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -12.95 -16.30 -18.75 -20.34 -20.44

SILO Pharma Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.53 -20.91 -20.44 -20.79 -20.20

SILO vs ELAB, GLMD, APVO: E10 Comparison

For the Biotechnology subindustry, SILO Pharma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SILO Pharma Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SILO Pharma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where SILO Pharma's Shiller PE Ratio falls into.


SILO
42GF Score
SILO Pharma Inc SILO
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SILO Pharma E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, SILO Pharma's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.76/333.9520*333.9520
=-0.760

Current CPI (Jun. 2026) = 333.9520.

SILO Pharma Quarterly Data

per share eps CPI Adj_EPS
201609 -6.462 241.428 -8.938
201612 -2.142 241.432 -2.963
201703 7.500 243.801 10.273
201706 -1.139 244.955 -1.553
201709 -7.774 246.819 -10.518
201712 3.098 246.524 4.197
201803 0.253 249.554 0.339
201806 -7.500 251.989 -9.939
201809 -2.966 252.439 -3.924
201812 -7.500 251.233 -9.969
201903 -7.500 254.202 -9.853
201906 -7.500 256.143 -9.778
201909 -7.500 256.759 -9.755
201912 -7.500 256.974 -9.747
202003 -7.500 258.115 -9.704
202006 -30.000 257.797 -38.862
202009 -7.500 260.280 -9.623
202012 -7.500 260.474 -9.616
202103 -22.500 264.877 -28.368
202106 -3.577 271.696 -4.397
202109 47.400 274.310 57.706
202112 -5.700 278.802 -6.828
202203 -4.650 287.504 -5.401
202206 -4.950 296.311 -5.579
202209 -7.350 296.808 -8.270
202212 -8.700 296.797 -9.789
202303 -4.350 301.836 -4.813
202306 -4.800 305.109 -5.254
202309 -3.150 307.789 -3.418
202312 -5.700 306.746 -6.206
202403 -4.200 312.332 -4.491
202406 -4.650 314.175 -4.943
202409 -3.300 315.301 -3.495
202412 -6.150 315.605 -6.508
202503 -3.450 319.799 -3.603
202506 -2.880 322.561 -2.982
202509 -1.800 324.800 -1.851
202512 -0.993 324.054 -1.023
202603 -1.800 330.213 -1.820
202606 -0.760 333.952 -0.760

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-20.20 mean?
SILO Pharma (SILO) has a E10 of $-20.20 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on SILO Pharma and its competitors.
Is SILO Pharma's E10 too high?
SILO Pharma's current E10 is $-20.20. Overall, SILO Pharma has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SILO Pharma's E10 compare to ELAB and GLMD?
SILO Pharma's E10 of $-20.20 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on SILO Pharma and its competitors. SILO Pharma's current E10 is $-20.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SILO Pharma stock overvalued right now?
Based on GuruFocus' analysis, SILO Pharma (SILO) is currently considered Possible Value Trap. The stock's GF Value™ is $3.44, compared to a current price of $2.10 — trading 39% below its estimated fair value. The current E10 is $-20.20. SILO Pharma's overall GF Score™ is 42/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For SILO Pharma (SILO), the current E10 is $-20.20 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SILO Pharma (SILO) Overvalued in 2026?

Based on GuruFocus' analysis, SILO Pharma stock appears to be undervalued. The current stock price of $2.10 is trading 39% below its estimated GF Value™ of $3.44. GuruFocus considers SILO Pharma to be Possible Value Trap.

Key valuation signals for SILO:

  • E10: $-20.20
  • GF Value™: $3.44 vs. price of $2.10 (39% below fair value)
  • GF Score™: 42/100 with 3 warning signs

No single metric tells the full story. See the SILO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SILO Pharma Business Description

Address 677 N. Washington Boulevard, Sarasota, FL, USA, 34236
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.
42GF Score

Get the complete analysis for SILO

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.10
Price
$3.44
GF Value